Sign In
Buy CODX
$5.17
-1.05 (-16.88%)
At Close: Jun 03, 2026
Why Co-Diagnostics Zoomed Almost 10% Higher Today
05:47pm, Friday, 13'th Aug 2021
The company notched beats on both trailing and anticipated revenue and earnings.
Co-Diagnostics Stock Moves Higher As Q2 Earnings Top Estimates
01:55pm, Friday, 13'th Aug 2021
Co-Diagnostics Inc's (NASDAQ: CODX) Q2 revenue increased 14% Y/Y to $27.4 million, primarily due to Logix Smart COVID-19 Test sales, beating the consensus of $20.77 million. Gross profit increased 3
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q2 2021 Results - Earnings Call Transcript
10:02pm, Thursday, 12'th Aug 2021
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q2 2021 Results - Earnings Call Transcript
CoDiagnostics, Inc. (CODX) Surpasses Q2 Earnings and Revenue Estimates
07:19pm, Thursday, 12'th Aug 2021
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of 43.48% and 30.28%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Co-Diagnostics sees 2Q revenue rise by 13.8% driven by sales of the Logix Smart COVID-19 Test
04:34pm, Thursday, 12'th Aug 2021
Co-Diagnostics (NASDAQ:CODX) Inc posted second-quarter results that saw pre-tax income of $11.9 million and year-over-year revenue gains driven by sales of the company's Logix Smart COVID-19 Test. For
Analysts Estimate CoDiagnostics, Inc. (CODX) to Report a Decline in Earnings: What to Look Out for
04:44pm, Thursday, 05'th Aug 2021
CoDiagnostics, Inc. (CODX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Co-Diagnostics, Inc. Announces Second Quarter 2021 Earnings Release Date And Webcast
11:30am, Wednesday, 04'th Aug 2021
SALT LAKE CITY, Aug. 4, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, a
Why Co-Diagnostics Blasted 21% Higher on Thursday
06:28pm, Thursday, 22'nd Jul 2021
The company was awarded a patent from a relatively affluent Asian country.
Why Co-Diagnostics Shares Are Skyrocketing Today
02:33pm, Thursday, 22'nd Jul 2021
Co-Diagnostics Inc (NASDAQ:CODX) shares are trading higher by 26.3% at $10.99 Thursday afternoon. The stock spiked earlier following reports suggesting the Biden Administration will announce it is d
Co-Diagnostics strengthens intellectual property portfolio with South Korean patent award for its CoPrimer technology
11:49am, Thursday, 22'nd Jul 2021
Co-Diagnostics Inc has strengthened its intellectual property portfolio after being awarded a patent in the Republic of Korea for the company's CoPrimer technology. Developed in 2013, Co-Diagnostics'
Co-Diagnostics, Inc. Strengthens Intellectual Property Portfolio with New International CoPrimer™ Patent
09:30am, Thursday, 22'nd Jul 2021
SALT LAKE CITY, July 22, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,
CODX Stock Increased 9.67%: Why It Happened
06:55am, Tuesday, 20'th Jul 2021
The stock price of Co-Diagnostics Inc (NASDAQ: CODX) increased by 9.67% yesterday. This is why it happened.
Strength Seen in CoDiagnostics, Inc. (CODX): Can Its 9.7% Jump Turn into More Strength?
04:35am, Tuesday, 20'th Jul 2021
CoDiagnostics, Inc. (CODX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength
Why Coronavirus Stocks Are Zooming Higher Today
03:12pm, Monday, 19'th Jul 2021
The surge in cases and deaths could significantly ramp up demand for these companies' existing and pipeline products.
Are Investors Undervaluing CoDiagnostics, Inc. (CODX) Right Now?
12:46pm, Thursday, 01'st Jul 2021
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
